Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 3

1.

CD133 and nuclear beta-catenin: the marker combination to detect high risk cases of low stage colorectal cancer.

Horst D, Kriegl L, Engel J, Jung A, Kirchner T.

Eur J Cancer. 2009 Jul;45(11):2034-40. doi: 10.1016/j.ejca.2009.04.004. Epub 2009 May 4.

PMID:
19403300
2.

CD133: a cancer stem cells marker, is used in colorectal cancers.

Ren F, Sheng WQ, Du X.

World J Gastroenterol. 2013 May 7;19(17):2603-11. doi: 10.3748/wjg.v19.i17.2603. Review.

3.

How powerful is CD133 as a cancer stem cell marker in brain tumors?

Cheng JX, Liu BL, Zhang X.

Cancer Treat Rev. 2009 Aug;35(5):403-8. doi: 10.1016/j.ctrv.2009.03.002. Epub 2009 Apr 14. Review.

PMID:
19369008

Supplemental Content

Support Center